Microdosing Safety & Risks
Explore mushroom research and guides on microdosing safety & risks.
Long-Term Microdosing Risks: What We Don't Know Yet
What happens when you microdose for a year? No controlled study has tracked it. The honest breakdown of six long-term risks that science hasn't tested.
Microdosing and Heart Health: The 5-HT2B Valvulopathy Concern
Psilocybin microdosing and the heart: explaining the 5-HT2B valvulopathy concern, what animal research shows about valve risk, and who should be most cautious.
Microdosing and Cardiac Valvulopathy: The 5-HT2B Risk
Psilocybin binds 5-HT2B receptors, the mechanism behind drug-induced heart valve disease. No confirmed human cases, but cardiac monitoring data is absent.
Microdosing Psilocybin Safety: What the Research Shows
Short-term controlled studies find microdosing psilocybin is generally safe for adults. Long-term safety data doesn't exist yet. Here's what the research shows.
Microdosing Side Effects: Survey Data on Adverse Experiences
Survey data puts anxiety in 25% of microdosers and headache in 20.4%. Here's how that compares to controlled trial evidence, and why the two sources disagree.